HAEM5:Volunteer Assignments and Opportunities: Difference between revisions

[unchecked revision][unchecked revision]
No edit summary
No edit summary
Line 608: Line 608:
|Myeloid/lymphoid neoplasm with PDGFRA rearrangement
|Myeloid/lymphoid neoplasm with PDGFRA rearrangement
|Disease
|Disease
|Jay Alden, DO
|
|
|
|
|
Line 616: Line 616:
|
|
|
|
|
|Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement
|
|Jay Alden, DO
|
|Complete
|
|
|
|
Line 624: Line 624:
|Myeloid/lymphoid neoplasm with PDGFRB rearrangement
|Myeloid/lymphoid neoplasm with PDGFRB rearrangement
|Disease
|Disease
|Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD
|
|
|
|
|
Line 632: Line 632:
|
|
|
|
|
|Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement
|
|Christopher Sullivan, MD, MPH and Daynna J. Wolff, PhD
|
|Complete
|
|
|
|
Line 640: Line 640:
|Myeloid/lymphoid neoplasm with FGFR1 rearrangement
|Myeloid/lymphoid neoplasm with FGFR1 rearrangement
|Disease
|Disease
|Yanna Ding, MD PhD
|
|
|
|
|
Line 648: Line 648:
|
|
|
|
|
|Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
|Yanna Ding, MD PhD
|
|Complete
|
|
|
|
Line 656: Line 656:
|Myeloid/lymphoid neoplasm with JAK2 rearrangement
|Myeloid/lymphoid neoplasm with JAK2 rearrangement
|Disease
|Disease
|Jessica Snider, M.D. and Daynna J. Wolff, PhD
|
|
|
|
|
Line 664: Line 664:
|
|
|
|
|
|Myeloid/Lymphoid Neoplasms with PCM1-JAK2 + a non-WHO page Myeloid/Lymphoid Neoplasms with ETV6-JAK2 ([[HAEM4:Myeloid/Lymphoid Neoplasms with ETV6-JAK2|Myeloid/Lymphoid Neoplasms with ETV6-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io)]])  + non-WHO page Myeloid/Lymphoid Neoplasms with BCR-JAK2 ([[HAEM4:Myeloid/Lymphoid Neoplasms with BCR-JAK2|Myeloid/Lymphoid Neoplasms with BCR-JAK2 - Compendium of Cancer Genome Aberrations (ccga.io)]] )  - both non-WHO pages are authored by trainee Lauren Crowson-Hindman and Daynna Wolff
|
|Jessica Snider, M.D. and Daynna J. Wolff, PhD + non-WHO pages by trainee Lauren Crowson-Hindman and Daynna Wolff
|
|Complete
|
|
|
|